Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 68180-854

10 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 68180-854). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fef28a30 7ad1 4c3c A283 06f533374be4 01)

Structure (Fef28a30 7ad1 4c3c A283 06f533374be4 01)
Chemical structure diagram showing Levonorgestrel (C21H28O2, M.W. 312.45) and Ethinyl Estradiol (C20H24O2, M.W. 296.4). Both molecular structures are depicted with structural formulae including key functional groups relevant to these compounds.*
FDA Label Image

Figure 1 (Fef28a30 7ad1 4c3c A283 06f533374be4 02)

Figure 1 (Fef28a30 7ad1 4c3c A283 06f533374be4 02)
Pharmacokinetic curves showing the concentration of Levonorgestrel and Ethinyl Estradiol over time in hours. The left graph displays Levonorgestrel concentration in ng/mL, and the right graph shows Ethinyl Estradiol concentration in pg/mL. Both graphs include data points for Day 1, Day 6, and Day 21 post-administration, illustrating changes in concentration levels over approximately 72 hours.*
FDA Label Image

Figure 2 (Fef28a30 7ad1 4c3c A283 06f533374be4 03)

Figure 2 (Fef28a30 7ad1 4c3c A283 06f533374be4 03)
A bar chart comparing four groups (Ever-Users Nonsmokers, Ever-Users Smokers, Controls Non-smokers, Controls Smokers) across age categories (15-24, 25-34, 35-44, 45+). The chart shows varying values for each group within age ranges, with the highest values observed in the 45+ category for Ever-Users Smokers and Controls Non-smokers.*
FDA Label Image

Image (Fef28a30 7ad1 4c3c A283 06f533374be4 04)

Image (Fef28a30 7ad1 4c3c A283 06f533374be4 04)
A forest plot chart titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' showing effect estimates from multiple studies. The horizontal axis represents the effect estimate with a range from -1.5 to 2. Each study is listed on the left, including the NICHD Women's Contraceptive Study, French E3N cohort, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The plot displays odds ratios/risk ratios with 95% confidence intervals for both 'Ever Use' and 'Current Use' groups.*
FDA Label Image

Image (Fef28a30 7ad1 4c3c A283 06f533374be4 05)

FDA Label Image

Lng Ee (Fef28a30 7ad1 4c3c A283 06f533374be4 06)

Lng Ee (Fef28a30 7ad1 4c3c A283 06f533374be4 06)
An instructional diagram showing a 28-day oral contraceptive pill schedule organized into four weekly rows labeled Week 1 to Week 4. Each row contains circles representing days of the week from Sunday to Saturday, with directional arrows guiding the user to take the pills in sequence. Annotations include 'START HERE' at the beginning and a reminder for 'MONTHLY SELF BREAST EXAM' along the side.*
FDA Label Image

Figure 3 (Fef28a30 7ad1 4c3c A283 06f533374be4 07)

Figure 3 (Fef28a30 7ad1 4c3c A283 06f533374be4 07)
An illustrated medication calendar for Levonorgestrel and Ethinyl Estradiol, showing a 28-day cycle divided into 4 weeks. Each week has circular slots labeled Sunday through Saturday, arranged with directional arrows to indicate the order of pill intake. The left side marks the starting point, and the right side includes a reminder for monthly self breast exam.*
FDA Label Image

Image (Fef28a30 7ad1 4c3c A283 06f533374be4 08)

FDA Label Image

Wallet (Fef28a30 7ad1 4c3c A283 06f533374be4 09)

Wallet (Fef28a30 7ad1 4c3c A283 06f533374be4 09)
Blister card packaging for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg by Lupin Pharmaceuticals, Inc. The lidding foil side includes dosing information, storage instructions, barcode, and manufacturer details. The forming foil/PVC side displays a 28-day calendar with circles for each day of the week, arranged in four rows labeled Week 1 to Week 4, guiding daily tablet use.*
FDA Label Image

Carton (Fef28a30 7ad1 4c3c A283 06f533374be4 10)

Carton (Fef28a30 7ad1 4c3c A283 06f533374be4 10)
Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg by Lupin Pharmaceuticals, Inc. The label displays the proprietary name, dosage strength, dosage form, and quantity (3 blisters of 28 tablets each). It includes barcodes, NDC 68180-854-73, manufacturer and distributor information, and usage warnings about the product not protecting against HIV/AIDS.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.